Literature DB >> 9607836

Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

C A Evans1, J Jellis, S P Hughes, D G Remick, J S Friedland.   

Abstract

Osteomyelitis, or bone infection, is a major worldwide cause of morbidity. Treatment is frequently unsatisfactory, yet little is known about pathogenesis of infection. Plasma tumor necrosis factor (TNF), interleukin (IL)-6, and IL-8 concentrations were measured before and after lipopolysaccharide stimulation of whole blood from patients with bacterial and tuberculous osteomyelitis and from controls. Patients with bacterial and tuberculous osteomyelitis mounted an acute-phase response and were anemic and febrile. However, plasma IL-6 concentrations were significantly elevated in only tuberculous osteomyelitis patients (vs. controls, P < .05). IL-6 concentrations correlated with erythrocyte sedimentation rate, C-reactive protein level, and plasma albumin concentration, all acute-phase markers. There were no other correlations between cytokine concentrations and clinical data. Following ex vivo stimulation, TNF, IL-6, and IL-8 were secreted equally by patients and controls. In summary, tuberculous osteomyelitis is characterized by elevated systemic IL-6 concentrations associated with an acute-phase response. For further insight into immunopathology of osteomyelitis, studies on infected bone are required.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607836      PMCID: PMC3034154          DOI: 10.1086/515313

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6.

Authors:  T R Ulich; K Z Guo; D Remick; J del Castillo; S M Yin
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

2.  Stimulation of antibacterial macrophage activities by B-cell stimulatory factor 2 (interleukin-6).

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.

Authors:  J G Cannon; R G Tompkins; J A Gelfand; H R Michie; G G Stanford; J W van der Meer; S Endres; G Lonnemann; J Corsetti; B Chernow
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

6.  Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.

Authors:  L E DeForge; D G Remick
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

7.  A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide.

Authors:  B M Wilson; A Severn; N T Rapson; J Chana; P Hopkins
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

8.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

9.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

Authors:  J C Mathison; E Wolfson; R J Ulevitch
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more
  17 in total

1.  Comparison of platelet count in tuberculosis spine to other spine pathology.

Authors:  Koshy Daniel; Robert Dunn
Journal:  Eur Spine J       Date:  2013-06-30       Impact factor: 3.134

2.  Free radicals and antioxidant status in chronic osteomyelitis patients: a case control study.

Authors:  Abha Jyoti; Saurababh Singh; Bedabrata Mukhopadhyay; Roshni Gavel; Surendra Pratap Mishra
Journal:  J Clin Diagn Res       Date:  2015-04-01

3.  Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.

Authors:  E Unsal; S Aksaray; D Köksal; T Sipit
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

4.  Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.

Authors:  Sameh Sarray; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

Review 5.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

6.  Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy.

Authors:  Christopher R Sudfeld; Sheila Isanaka; Said Aboud; Ferdinand M Mugusi; Molin Wang; Guerino E Chalamilla; Wafaie W Fawzi
Journal:  J Infect Dis       Date:  2013-01-14       Impact factor: 5.226

7.  Influence of interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis.

Authors:  Aspasia Tsezou; Lazaros Poultsides; Fotini Kostopoulou; Elias Zintzaras; Maria Satra; Sofia Kitsiou-Tzeli; Konstantinos N Malizos
Journal:  Clin Vaccine Immunol       Date:  2008-10-29

8.  In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis.

Authors:  Víctor Asensi; Eulalia Valle; Alvaro Meana; Joshua Fierer; Antonio Celada; Victoria Alvarez; José Paz; Eliecer Coto; José Antonio Carton; José Antonio Maradona; Angeles Dieguez; Julián Sarasúa; Marcos G Ocaña; José Manuel Arribas
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Osteoarthritic process modifies expression response to NiTi alloy presence.

Authors:  Lucie Válková; Jana Ševčíková; Monika Pávková Goldbergová; Adam Weiser; Antonín Dlouhý
Journal:  J Mater Sci Mater Med       Date:  2018-08-30       Impact factor: 3.896

10.  Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis.

Authors:  Amro Widaa; Tania Claro; Timothy J Foster; Fergal J O'Brien; Steven W Kerrigan
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.